SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031250
Filing Date
2023-11-09
Accepted
2023-11-09 16:06:52
Documents
73
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q omer20230930_10q.htm   iXBRL 10-Q 1070599
2 EXHIBIT 31.1 ex_567193.htm EX-31.1 12797
3 EXHIBIT 31.2 ex_567194.htm EX-31.2 13545
4 EXHIBIT 32.1 ex_567195.htm EX-32.1 6509
5 EXHIBIT 32.2 ex_567196.htm EX-32.2 6517
  Complete submission text file 0001437749-23-031250.txt   6006899

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA omer-20230930.xsd EX-101.SCH 63179
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omer-20230930_cal.xml EX-101.CAL 56882
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20230930_def.xml EX-101.DEF 377099
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20230930_lab.xml EX-101.LAB 329954
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20230930_pre.xml EX-101.PRE 402949
67 EXTRACTED XBRL INSTANCE DOCUMENT omer20230930_10q_htm.xml XML 1011019
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 231392360
SIC: 2834 Pharmaceutical Preparations